Screener
Twist Bioscience Corporation TWST Reportable Segment — Impairment of long-lived assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The source filing: Twist Bioscience Corporation’s 10-K, filed November 17, 2025.
- Filed
- Nov 17, 2025
- Fiscal year
- FY2025
- Accession
- 0001581280-25-000025
| (In thousands) | Year ended September 30, 2025 | Year ended September 30, 2024 | Year ended September 30, 2023 |
|---|---|---|---|
| Stock-based compensation expense | 64,459 | 50,925 | 30,278 |
| Restructuring and other costs | — | — | 9,384 |
| Change in fair value of contingent considerations and holdbacks | — | — | (5,913) |
| Impairment of long-lived assets | — | 44,930 | 6,785 |
| Total costs and expenses | $512,831 | $533,805 | $462,268 |
| Loss from operations | $(136,259) | $(220,831) | $(217,159) |
| Gain on sale of business | $48,847 | — | — |
| Interest income | 11,364 | 15,344 | 14,365 |
Item 8. tatements and
FAQ
- What is Twist Bioscience Corporation's reportable segment — impairment of long-lived assets?
- Twist Bioscience Corporation (TWST) reported reportable segment — impairment of long-lived assets of $0 in Q3 2025.
- How has Twist Bioscience Corporation's reportable segment — impairment of long-lived assets changed year-over-year?
- Twist Bioscience Corporation's reportable segment — impairment of long-lived assets decreased by 100.0% year-over-year, from $11.23M to $0.
- What is the long-term trend for Twist Bioscience Corporation's reportable segment — impairment of long-lived assets?
- Over 2 years (2023 to 2025), Twist Bioscience Corporation's reportable segment — impairment of long-lived assets has grown at a -100.0% compound annual growth rate (CAGR), from $6.79M to $0.
- What does reportable segment — impairment of long-lived assets mean?
- This represents a non-cash charge recognized when the carrying value of the reportable segment's long-term assets, such as property, plant, or equipment, exceeds their recoverable amount. It serves as an indicator that the expected future economic benefits from these assets have declined. Significant impairments often signal a strategic reassessment of the segment's asset base or market conditions.
Ask your AI about Twist Bioscience Corporation's reportable segment — impairment of long-lived assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude